Novonesis A/S

Equities

NSIS B

DK0060336014

Specialty Chemicals

Real-time Estimate Cboe Europe 03:23:05 2024-04-19 am EDT 5-day change 1st Jan Change
380 DKK -0.69% Intraday chart for Novonesis A/S -1.17% +2.26%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Novozymes A/S Proposes Dividend for the Last Four Months Ended December 31, 2023 CI
China to speed up 'new productive forces', vice president says RE
Nordic Shares Rose Thursday; Embracer Group Series B Topped Leaders DJ
Transcript : Novozymes A/S, 2024 Guidance/Update Call, Mar 21, 2024
Novonensis expects 2024 adjusted EBITDA margin of 35% RE
Novonesis Provides Earnings Guidance for the Year 2024 CI
Biotalys, Novonesis Sign Deal to Advance Biofungicide Candidate Development MT
Biotalys and Novonesis Announces Manufacturing and Commercialization Partnership for EVOCA NG CI
FMC Partners With Novonesis in Canada for Biosolution Products MT
Novonesis to Unveil Fit-for-Food Mood-Support Probiotic at Natural Product Expo West CI
Novozymes A/S Announces Board Appointments CI
Transcript : Novozymes A/S - Shareholder/Analyst Call
Novo Nordisk's controlling shareholder plans to invest about $35 billion by 2030 RE
Novozymes A/S Reports Earnings Results for the Full Year Ended December 31, 2023 CI
NOVOZYMES : Q4 23: destocking noise offsets recovery in other key segments Alphavalue
Novozymes, Chr. Hansen Complete Merger Settlement MT
Transcript : Novozymes A/S, 2023 Earnings Call, Feb 01, 2024
Novozymes Completes Merger with Chr. Hansen After Securing Final Registration, Issuing B Shares MT
Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S. CI
Novozymes, Chr. Hansen’s Proposed Merger Secures All Regulatory Approvals MT
Novozymes, Chr. Hansen Merger Wins Korean Regulatory Nod MT
Global markets live: BAE Systems, Amazon, Take-Two, Shell, Pfizer... Our Logo
Celadon Pharma raises GBP2.0 million via placing AN
Novozymes-Chr. Hansen Merger Gets EU Nod After Proposed Asset Sale MT
Kerry Group Buys Novozymes, Chr. Hansen Assets for EUR150 Million DJ
Chart Novonesis A/S
More charts
Novonesis A/S (formerly Novozymes A/S) is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows: - industry of cleaning and household maintenance products (28.5%); - bioenergy (24.8%); - food industry and human health (22.1%); - technical and cereal industries (12.8%): microorganisms used in the field of wastewater treatment, technical enzymes intended for the textile, leather, pulp and paper industries; - agriculture and animal feed industry (11.8%): enzymes used to improve the productivity and digestion of certain foods. Net sales are geographically distributed as follows: Denmark (1.3%), Europe/Middle East/Africa (33.5%), North America (33.9%), Asia/Pacific (18.5%) and Latin America (12.8%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
382.7 DKK
Average target price
430.9 DKK
Spread / Average Target
+12.58%
Consensus
  1. Stock Market
  2. Equities
  3. NSIS B Stock
  4. News Novonesis A/S
  5. Novozymes A/S : Expects To Double Revenue By 2030 Amid New Organic Growth Strategy